The global COVID-19 pandemic has led to a race to find medications that can improve the
prognosis of the disease. Azithromycin, in association with hydroxychloroquine or …

Introduction SARS-CoV-2 is a novel virus that causes coronavirus disease-19 (COVID-19).
Antiviral and immunomodulatory agents have been proposed as potential treatments …

Background There are no established effective treatments for COVID-19. While novel drugs
are being developed, azithromycin has been identified as a candidate treatment in the …

Azithromycin (AZ) is a broad‐spectrum macrolide antibiotic with a long half‐life and a large
volume of distribution. It is primarily used for the treatment of respiratory, enteric, and …

As no specific pharmacological treatment has been validated for use in coronavirus disease
2019 (COVID-19), we aimed to assess the effectiveness of azithromycin (AZM) in these …

Azithromycin (AZM) is commonly used in Covid‐19 patients based on low‐quality evidence,
increasing the risk of developing adverse events and antimicrobial resistance. The current …

Azithromycin has rapidly been adopted as a repurposed drug for the treatment of COVID-19,
despite the lack of high-quality evidence. In this review, we critically appraise the current …

Background Azithromycin has been proposed as a treatment for COVID-19 on the basis of
its immunomodulatory actions. We aimed to evaluate the safety and efficacy of azithromycin …

The emergence of the new COVID-19 virus is proving to be a challenge in seeking effective
therapies. Since the most severe clinical manifestation of COVID-19 appears to be a severe …

Background Combining the antibiotic azithromycin and hydroxychloroquine induces airway
immunomodulatory effects, with the latter also having in vitro antiviral properties. This may …